华润医药旗下公司启动对合肥天麦生物科技发展17.87%股权的潜在处置计划

美股速递
Feb 09

华润医药旗下关联单位已着手启动一项潜在交易,拟处置其持有的合肥天麦生物科技发展有限公司17.87%的股权。此次股权变动可能涉及重大资产重组,目前相关方案尚在初步筹划阶段。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10